Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Todd Pitts

Concepts (396)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Colorectal Neoplasms
24
2024
752
2.930
 Why?
Xenograft Model Antitumor Assays
38
2024
812
2.020
 Why?
Protein Kinase Inhibitors
19
2020
890
1.870
 Why?
Antineoplastic Agents
25
2020
2054
1.460
 Why?
Triple Negative Breast Neoplasms
7
2024
197
1.440
 Why?
Azepines
5
2024
88
1.400
 Why?
Histone Deacetylase Inhibitors
5
2024
209
1.240
 Why?
Pyrimidines
9
2020
459
1.180
 Why?
Cell Line, Tumor
37
2025
3202
1.170
 Why?
Mice, Nude
25
2024
682
1.150
 Why?
Pyrazines
6
2018
86
1.020
 Why?
Cell Proliferation
22
2024
2375
0.960
 Why?
Pancreatic Neoplasms
6
2024
881
0.910
 Why?
Carcinoma, Pancreatic Ductal
2
2024
270
0.850
 Why?
Apoptosis
22
2024
2499
0.780
 Why?
Fluorouracil
1
2022
198
0.750
 Why?
Proto-Oncogene Proteins
6
2018
635
0.640
 Why?
Benzimidazoles
6
2024
162
0.630
 Why?
Camptothecin
5
2022
110
0.630
 Why?
Imidazoles
4
2018
234
0.630
 Why?
Aurora Kinase A
4
2020
54
0.630
 Why?
Drug Resistance, Neoplasm
12
2024
756
0.590
 Why?
Antineoplastic Combined Chemotherapy Protocols
10
2024
1556
0.570
 Why?
Drug Synergism
4
2014
370
0.550
 Why?
Mice
42
2025
16915
0.550
 Why?
Neoplasms
9
2022
2449
0.520
 Why?
Cell Cycle Proteins
2
2018
584
0.500
 Why?
Wnt Signaling Pathway
5
2024
170
0.490
 Why?
Cell Cycle Checkpoints
3
2019
95
0.480
 Why?
Hydroxamic Acids
3
2011
88
0.480
 Why?
Deoxycytidine
3
2024
165
0.480
 Why?
Melanoma
5
2024
729
0.470
 Why?
Animals
47
2025
35309
0.470
 Why?
Receptor, IGF Type 1
3
2013
65
0.470
 Why?
Disease Models, Animal
11
2025
4057
0.460
 Why?
Pyrazoles
5
2018
404
0.450
 Why?
Gene Expression Regulation, Neoplastic
10
2024
1344
0.440
 Why?
Adrenocortical Carcinoma
3
2020
63
0.440
 Why?
Antimitotic Agents
1
2013
8
0.440
 Why?
Tumor Microenvironment
5
2022
631
0.440
 Why?
Mitogen-Activated Protein Kinases
3
2014
311
0.440
 Why?
Tumor Suppressor Protein p53
5
2024
509
0.430
 Why?
Molecular Targeted Therapy
3
2024
390
0.430
 Why?
Signal Transduction
18
2024
4926
0.410
 Why?
G2 Phase Cell Cycle Checkpoints
4
2022
45
0.410
 Why?
TOR Serine-Threonine Kinases
2
2018
396
0.410
 Why?
Cyclin-Dependent Kinases
1
2013
129
0.400
 Why?
Boronic Acids
2
2011
37
0.400
 Why?
Quinoxalines
4
2020
64
0.380
 Why?
Dasatinib
2
2024
54
0.360
 Why?
Gene Expression Profiling
8
2024
1688
0.350
 Why?
Colonic Neoplasms
2
2013
242
0.350
 Why?
Humans
67
2025
129266
0.340
 Why?
Biomarkers, Tumor
6
2018
1173
0.340
 Why?
Drug Screening Assays, Antitumor
5
2020
193
0.340
 Why?
Heterografts
3
2021
131
0.340
 Why?
Programmed Cell Death 1 Receptor
3
2025
232
0.330
 Why?
Oxidoreductases Acting on CH-CH Group Donors
2
2020
23
0.320
 Why?
Phosphatidylinositol 3-Kinases
6
2018
360
0.310
 Why?
Adrenal Cortex Neoplasms
2
2020
60
0.290
 Why?
Cell Cycle
7
2018
589
0.290
 Why?
Ephrin-B2
2
2019
50
0.280
 Why?
Enzyme Inhibitors
5
2020
827
0.280
 Why?
Piperazines
2
2020
341
0.280
 Why?
Drug Delivery Systems
1
2010
333
0.270
 Why?
Antibodies, Monoclonal, Humanized
2
2024
758
0.270
 Why?
Quinazolines
3
2015
244
0.270
 Why?
Female
41
2025
68551
0.260
 Why?
Anilides
2
2018
72
0.260
 Why?
Oncogene Proteins, Fusion
2
2018
200
0.260
 Why?
Mitogen-Activated Protein Kinase Kinases
3
2019
131
0.250
 Why?
Organoids
2
2024
104
0.250
 Why?
Mutation
9
2018
3710
0.240
 Why?
Gene Dosage
4
2015
143
0.240
 Why?
Nephritis, Interstitial
1
2025
13
0.240
 Why?
Gene Regulatory Networks
2
2024
280
0.240
 Why?
Immunoblotting
6
2015
305
0.230
 Why?
Cyclosporine
2
2018
263
0.230
 Why?
Pyrimidinones
2
2015
103
0.230
 Why?
Proto-Oncogene Proteins B-raf
3
2018
209
0.230
 Why?
RNA, Small Interfering
2
2024
591
0.220
 Why?
Lymphocytes, Tumor-Infiltrating
3
2020
207
0.220
 Why?
Endogenous Retroviruses
1
2024
34
0.220
 Why?
ras Proteins
4
2013
144
0.220
 Why?
Bevacizumab
1
2024
129
0.220
 Why?
Proto-Oncogene Proteins p21(ras)
6
2016
259
0.220
 Why?
Pyridones
2
2015
159
0.210
 Why?
Receptor, Notch1
2
2015
61
0.210
 Why?
Mucous Membrane
1
2024
122
0.210
 Why?
Neoplasm Transplantation
4
2018
256
0.210
 Why?
Paclitaxel
1
2024
217
0.200
 Why?
Pyridines
2
2018
478
0.200
 Why?
Antineoplastic Agents, Immunological
3
2020
181
0.200
 Why?
Ataxia Telangiectasia Mutated Proteins
1
2022
66
0.200
 Why?
HCT116 Cells
3
2018
78
0.200
 Why?
Immunotherapy
3
2022
592
0.200
 Why?
Doxorubicin
1
2024
328
0.190
 Why?
Drug Design
2
2013
156
0.190
 Why?
beta Catenin
2
2020
223
0.190
 Why?
Gene Knockdown Techniques
4
2020
316
0.180
 Why?
Momordica charantia
1
2020
15
0.170
 Why?
DNA-Binding Proteins
2
2020
1446
0.170
 Why?
Benzoxazoles
1
2020
20
0.170
 Why?
HT29 Cells
2
2018
36
0.170
 Why?
Neoplasms, Experimental
2
2019
170
0.170
 Why?
Immune System
1
2021
175
0.160
 Why?
eIF-2 Kinase
1
2019
30
0.160
 Why?
src-Family Kinases
2
2017
95
0.160
 Why?
Inhibitory Concentration 50
2
2016
86
0.160
 Why?
Receptor, EphB4
1
2019
36
0.150
 Why?
Tumor Burden
2
2018
286
0.150
 Why?
DNA Helicases
1
2020
149
0.150
 Why?
Breast Neoplasms, Male
1
2018
29
0.150
 Why?
Coenzymes
1
2018
19
0.150
 Why?
Plant Extracts
1
2020
198
0.150
 Why?
4-Aminobenzoic Acid
1
2018
7
0.150
 Why?
Neoplasm Proteins
2
2020
422
0.150
 Why?
Thermodynamics
1
2020
406
0.150
 Why?
MAP Kinase Kinase Kinases
2
2015
71
0.150
 Why?
Septins
1
2018
43
0.140
 Why?
Adrenal Cortex
1
2018
27
0.140
 Why?
Oncogene Proteins v-abl
1
2017
5
0.140
 Why?
Neoplasm Invasiveness
3
2020
483
0.140
 Why?
Colorectal Neoplasms, Hereditary Nonpolyposis
1
2018
33
0.140
 Why?
Kidney
1
2025
1385
0.140
 Why?
Angiogenesis Inhibitors
3
2018
220
0.140
 Why?
Vascular Endothelial Growth Factor Receptor-2
2
2014
84
0.130
 Why?
Ubiquitin-Activating Enzymes
1
2016
16
0.130
 Why?
Cyclopentanes
1
2016
19
0.130
 Why?
Skin Neoplasms
1
2024
824
0.130
 Why?
Transplantation, Heterologous
4
2022
192
0.130
 Why?
Tumor Cells, Cultured
4
2020
942
0.130
 Why?
Corynebacterium
1
2017
48
0.130
 Why?
Corynebacterium Infections
1
2017
40
0.130
 Why?
Tankyrases
1
2016
14
0.130
 Why?
Insulin-Like Growth Factor I
1
2018
307
0.130
 Why?
Cetuximab
1
2016
94
0.130
 Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2016
117
0.130
 Why?
Capecitabine
1
2015
46
0.130
 Why?
Biliary Tract Neoplasms
1
2015
25
0.120
 Why?
Autophagy
1
2018
266
0.120
 Why?
Amyloid Precursor Protein Secretases
2
2013
79
0.120
 Why?
Drug Discovery
1
2016
131
0.120
 Why?
Genes, ras
2
2018
96
0.120
 Why?
Adenocarcinoma
2
2020
898
0.120
 Why?
Cell Survival
3
2019
1075
0.120
 Why?
Diphenylamine
1
2014
9
0.120
 Why?
Gene Expression Regulation
1
2024
2537
0.110
 Why?
Germ-Line Mutation
2
2018
140
0.110
 Why?
Middle Aged
14
2024
31090
0.110
 Why?
DNA Copy Number Variations
1
2015
168
0.110
 Why?
Piperidines
1
2015
198
0.110
 Why?
Proto-Oncogene Proteins c-met
1
2014
74
0.110
 Why?
Benzamides
1
2014
207
0.110
 Why?
Aged
11
2024
22032
0.110
 Why?
Urinary Bladder Neoplasms
1
2016
226
0.110
 Why?
Protein Kinases
1
2015
318
0.110
 Why?
Up-Regulation
1
2016
839
0.110
 Why?
Receptor, Insulin
1
2013
99
0.110
 Why?
Tetrahydronaphthalenes
1
2013
30
0.100
 Why?
Valine
1
2013
81
0.100
 Why?
Neutrophils
4
2019
1207
0.100
 Why?
Bortezomib
2
2011
45
0.100
 Why?
Receptors, Notch
1
2013
84
0.100
 Why?
Mitosis
1
2013
180
0.100
 Why?
Tumor Suppressor Proteins
1
2015
314
0.100
 Why?
Antineoplastic Agents, Phytogenic
1
2013
187
0.090
 Why?
3' Untranslated Regions
1
2012
137
0.090
 Why?
Carcinoma, Squamous Cell
1
2016
625
0.090
 Why?
Head and Neck Neoplasms
1
2016
543
0.090
 Why?
Aldehyde Dehydrogenase
1
2012
101
0.090
 Why?
Computational Biology
1
2015
595
0.090
 Why?
Sirolimus
1
2013
266
0.090
 Why?
Proteasome Inhibitors
1
2011
42
0.090
 Why?
Benzodioxoles
1
2012
105
0.090
 Why?
Carcinogenesis
2
2024
213
0.090
 Why?
Protease Inhibitors
1
2011
106
0.090
 Why?
Proto-Oncogene Proteins c-akt
4
2018
431
0.080
 Why?
Nuclear Proteins
1
2015
659
0.080
 Why?
Neoplasm Metastasis
3
2018
610
0.080
 Why?
Mice, Inbred NOD
2
2022
588
0.080
 Why?
Phosphorylation
4
2019
1710
0.080
 Why?
Adult
12
2024
35495
0.080
 Why?
Vascular Endothelial Growth Factor Receptor-3
1
2009
7
0.080
 Why?
Mice, Inbred BALB C
3
2020
1247
0.080
 Why?
Breast Neoplasms
2
2012
2140
0.080
 Why?
Vascular Endothelial Growth Factor Receptor-1
1
2009
70
0.080
 Why?
Class I Phosphatidylinositol 3-Kinases
3
2014
81
0.080
 Why?
Male
15
2024
63512
0.080
 Why?
Gastrointestinal Neoplasms
1
2009
72
0.080
 Why?
Carcinoma, Hepatocellular
1
2011
272
0.080
 Why?
Cell Movement
2
2011
944
0.080
 Why?
Positron-Emission Tomography
3
2018
286
0.070
 Why?
Immunosuppressive Agents
1
2013
854
0.070
 Why?
Prognosis
4
2019
3773
0.070
 Why?
Farnesyltranstransferase
1
2007
35
0.070
 Why?
Oligonucleotide Array Sequence Analysis
3
2015
756
0.070
 Why?
Feasibility Studies
1
2010
867
0.060
 Why?
Protein Conformation
2
2020
861
0.060
 Why?
Algorithms
3
2024
1613
0.060
 Why?
Microsatellite Repeats
2
2024
164
0.060
 Why?
Gene Expression
2
2019
1466
0.060
 Why?
Transcription, Genetic
2
2024
1416
0.060
 Why?
Maximum Tolerated Dose
2
2020
193
0.060
 Why?
Reproducibility of Results
2
2010
3080
0.060
 Why?
Quinolones
1
2007
126
0.060
 Why?
Ipilimumab
1
2025
31
0.060
 Why?
Neovascularization, Pathologic
2
2018
296
0.060
 Why?
CTLA-4 Antigen
1
2025
87
0.060
 Why?
Models, Molecular
2
2020
1487
0.060
 Why?
Structure-Activity Relationship
2
2018
548
0.050
 Why?
Myeloid Cell Leukemia Sequence 1 Protein
2
2019
40
0.050
 Why?
Enhancer Elements, Genetic
1
2024
176
0.050
 Why?
Triazoles
1
2024
151
0.050
 Why?
HMGB1 Protein
1
2003
48
0.050
 Why?
Magnetic Resonance Spectroscopy
2
2018
538
0.050
 Why?
Adrenergic alpha-Agonists
1
2002
28
0.050
 Why?
Proto-Oncogene Proteins c-raf
1
2002
45
0.050
 Why?
Adrenergic alpha-Antagonists
1
2002
33
0.050
 Why?
Neuroimmunomodulation
1
2002
69
0.050
 Why?
Histone Deacetylase 1
1
2022
24
0.050
 Why?
Treatment Outcome
4
2024
10202
0.050
 Why?
Histones
2
2022
588
0.050
 Why?
Isoenzymes
1
2003
302
0.050
 Why?
Aurora Kinases
2
2012
28
0.050
 Why?
Adrenergic beta-Agonists
1
2002
132
0.050
 Why?
Endotoxemia
1
2002
86
0.050
 Why?
Genetic Predisposition to Disease
1
2010
2276
0.050
 Why?
Caspase 3
2
2013
245
0.050
 Why?
Chimerism
1
2021
31
0.050
 Why?
Acetylation
1
2022
244
0.050
 Why?
Flow Cytometry
2
2019
1155
0.040
 Why?
Campylobacter jejuni
1
2000
11
0.040
 Why?
Lymphoid Tissue
1
2021
67
0.040
 Why?
Lymphocyte Subsets
1
2021
84
0.040
 Why?
Cluster Analysis
2
2012
479
0.040
 Why?
Catalase
1
2000
128
0.040
 Why?
TCF Transcription Factors
1
2020
16
0.040
 Why?
Adrenergic beta-Antagonists
1
2002
321
0.040
 Why?
Histone Deacetylases
1
2022
212
0.040
 Why?
Mice, SCID
1
2021
350
0.040
 Why?
RNA, Neoplasm
1
2020
87
0.040
 Why?
Antimetabolites, Antineoplastic
1
2020
91
0.040
 Why?
Mechanistic Target of Rapamycin Complex 2
1
2020
62
0.040
 Why?
Indolizines
1
2019
4
0.040
 Why?
Forkhead Box Protein M1
1
2019
7
0.040
 Why?
Mechanistic Target of Rapamycin Complex 1
1
2020
119
0.040
 Why?
Small Molecule Libraries
1
2020
86
0.040
 Why?
Genomics
1
2024
717
0.040
 Why?
MAP Kinase Kinase 2
2
2013
29
0.040
 Why?
Crystallography, X-Ray
1
2020
435
0.040
 Why?
MAP Kinase Kinase 1
2
2013
76
0.040
 Why?
High-Throughput Screening Assays
1
2020
138
0.040
 Why?
M Phase Cell Cycle Checkpoints
1
2018
24
0.040
 Why?
Genetic Linkage
1
1999
299
0.040
 Why?
Flavin-Adenine Dinucleotide
1
2018
14
0.040
 Why?
NADP
1
2018
46
0.040
 Why?
Epithelial-Mesenchymal Transition
1
2020
201
0.040
 Why?
Radiotherapy
1
2019
185
0.040
 Why?
Multifactorial Inheritance
1
1999
150
0.040
 Why?
Nausea
1
2018
110
0.040
 Why?
Aldosterone
1
2018
43
0.040
 Why?
Hemorrhage
1
2002
678
0.040
 Why?
Kaplan-Meier Estimate
1
2020
851
0.040
 Why?
DNA Damage
1
2020
383
0.040
 Why?
Area Under Curve
1
2018
304
0.040
 Why?
Drug Therapy, Combination
1
2020
1040
0.040
 Why?
Breast
1
2018
153
0.040
 Why?
RNA
1
2024
880
0.030
 Why?
Diarrhea
1
2018
180
0.030
 Why?
Catalytic Domain
1
2018
218
0.030
 Why?
Recombinant Proteins
1
2020
1304
0.030
 Why?
Autistic Disorder
1
1999
189
0.030
 Why?
Disease-Free Survival
1
2018
645
0.030
 Why?
RNA, Messenger
2
2020
2703
0.030
 Why?
Axin Protein
1
2016
19
0.030
 Why?
Ubiquitination
1
2016
98
0.030
 Why?
Fatigue
1
2018
316
0.030
 Why?
Sequence Analysis, RNA
1
2018
428
0.030
 Why?
T-Lymphocytes, Regulatory
1
2019
373
0.030
 Why?
Administration, Oral
1
2018
785
0.030
 Why?
Protein Isoforms
1
2017
389
0.030
 Why?
Hypertension
2
2018
1242
0.030
 Why?
Serrate-Jagged Proteins
1
2015
27
0.030
 Why?
Jagged-1 Protein
1
2015
23
0.030
 Why?
Hematopoietic Stem Cell Transplantation
1
2021
572
0.030
 Why?
Tumor Protein p73
1
2015
14
0.030
 Why?
Gene Duplication
1
2015
67
0.030
 Why?
Binding Sites
1
2018
1250
0.030
 Why?
Biopsy
1
2018
1092
0.030
 Why?
Immunohistochemistry
1
2019
1691
0.030
 Why?
NF-kappa B
3
2003
665
0.030
 Why?
Databases, Genetic
1
2015
230
0.030
 Why?
Mice, Knockout
1
2021
2871
0.030
 Why?
Calcium-Binding Proteins
1
2015
211
0.030
 Why?
Caspase 7
1
2013
22
0.030
 Why?
Butadienes
1
2013
36
0.030
 Why?
Intercellular Signaling Peptides and Proteins
1
2015
374
0.030
 Why?
Cell Growth Processes
1
2013
52
0.030
 Why?
Survival Analysis
1
2016
1269
0.030
 Why?
Tumor Stem Cell Assay
1
2012
32
0.030
 Why?
Everolimus
1
2013
88
0.030
 Why?
CD8-Positive T-Lymphocytes
1
2019
857
0.030
 Why?
Nitriles
1
2013
172
0.020
 Why?
Random Allocation
1
2013
346
0.020
 Why?
Phenotype
1
2021
3074
0.020
 Why?
Neoplasm Staging
1
2015
1290
0.020
 Why?
Cyclic AMP Response Element-Binding Protein
2
2003
141
0.020
 Why?
Immunoprecipitation
1
2012
157
0.020
 Why?
p38 Mitogen-Activated Protein Kinases
2
2003
275
0.020
 Why?
Calcium Signaling
1
2013
250
0.020
 Why?
Kinetics
1
2014
1644
0.020
 Why?
Cellular Senescence
1
2012
181
0.020
 Why?
In Situ Hybridization, Fluorescence
1
2012
313
0.020
 Why?
Enzyme Activation
2
2003
812
0.020
 Why?
PTEN Phosphohydrolase
1
2012
161
0.020
 Why?
Disease Progression
1
2018
2630
0.020
 Why?
Li-Fraumeni Syndrome
1
2010
13
0.020
 Why?
Proteasome Endopeptidase Complex
1
2011
148
0.020
 Why?
Receptor, ErbB-2
1
2012
326
0.020
 Why?
Molecular Epidemiology
1
2010
63
0.020
 Why?
Nuclear Magnetic Resonance, Biomolecular
1
2011
257
0.020
 Why?
Neutropenia
1
2010
136
0.020
 Why?
Population Groups
1
2010
60
0.020
 Why?
Ki-67 Antigen
1
2010
108
0.020
 Why?
Metabolome
1
2013
338
0.020
 Why?
Capillary Permeability
1
2010
140
0.020
 Why?
Ligands
1
2011
621
0.020
 Why?
Drug Combinations
1
2010
330
0.020
 Why?
Transcriptome
1
2015
874
0.020
 Why?
Australia
1
2010
243
0.020
 Why?
Keratinocytes
1
2010
242
0.020
 Why?
Membrane Proteins
1
2015
1117
0.020
 Why?
Antibodies, Monoclonal
1
2015
1367
0.020
 Why?
Biomarkers
1
2019
3968
0.020
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2009
947
0.020
 Why?
Leukemia-Lymphoma, Adult T-Cell
1
2007
13
0.020
 Why?
Sulfonamides
1
2011
495
0.020
 Why?
Enzyme-Linked Immunosorbent Assay
1
2009
833
0.020
 Why?
Verapamil
1
2007
41
0.020
 Why?
Calcium
1
2013
1212
0.020
 Why?
Blotting, Western
1
2009
1204
0.020
 Why?
Clone Cells
1
2007
262
0.020
 Why?
Magnetic Resonance Imaging
1
2018
3386
0.020
 Why?
Dose-Response Relationship, Drug
1
2010
2011
0.020
 Why?
Calcium Channel Blockers
1
2007
161
0.020
 Why?
Liver Neoplasms
1
2011
640
0.020
 Why?
Family
1
2010
644
0.020
 Why?
Metabolomics
1
2011
652
0.020
 Why?
MicroRNAs
1
2012
676
0.020
 Why?
Cohort Studies
1
2015
5409
0.020
 Why?
Ovarian Neoplasms
1
2010
489
0.010
 Why?
Phosphotransferases
1
2003
24
0.010
 Why?
Class Ib Phosphatidylinositol 3-Kinase
1
2003
4
0.010
 Why?
bcl-Associated Death Protein
1
2003
10
0.010
 Why?
Phentolamine
1
2002
14
0.010
 Why?
Ribosomal Protein S6 Kinases
1
2002
21
0.010
 Why?
Brimonidine Tartrate
1
2002
9
0.010
 Why?
Adolescent
2
2018
20313
0.010
 Why?
Propranolol
1
2002
50
0.010
 Why?
Phenylephrine
1
2002
75
0.010
 Why?
Mice, Mutant Strains
1
2003
297
0.010
 Why?
Chemokines
1
2003
226
0.010
 Why?
Peroxidase
1
2002
174
0.010
 Why?
Young Adult
1
2018
12391
0.010
 Why?
Mitogen-Activated Protein Kinase 3
1
2002
151
0.010
 Why?
Biological Transport
1
2003
404
0.010
 Why?
Proto-Oncogene Proteins c-bcl-2
1
2003
232
0.010
 Why?
Cyclic AMP-Dependent Protein Kinases
1
2002
132
0.010
 Why?
Respiratory Burst
1
2000
15
0.010
 Why?
omega-N-Methylarginine
1
2000
26
0.010
 Why?
MAP Kinase Signaling System
1
2002
313
0.010
 Why?
Inflammation Mediators
1
2003
505
0.010
 Why?
Protein Processing, Post-Translational
1
2002
454
0.010
 Why?
Statistical Distributions
1
1999
8
0.010
 Why?
Cloning, Molecular
1
2000
525
0.010
 Why?
Matched-Pair Analysis
1
1999
40
0.010
 Why?
Intelligence Tests
1
1999
57
0.010
 Why?
Chromosomes, Human
1
1999
41
0.010
 Why?
Nuclear Family
1
1999
51
0.010
 Why?
Lipopolysaccharides
1
2003
877
0.010
 Why?
Hydrogen Peroxide
1
2000
318
0.010
 Why?
Protein-Tyrosine Kinases
1
2002
432
0.010
 Why?
Linkage Disequilibrium
1
1999
257
0.010
 Why?
Carrier Proteins
1
2003
742
0.010
 Why?
Models, Genetic
1
1999
593
0.010
 Why?
Cells, Cultured
1
2003
4077
0.010
 Why?
Cytokines
1
2003
2013
0.010
 Why?
Cell Line
1
2000
2779
0.010
 Why?
Molecular Sequence Data
1
1999
2835
0.010
 Why?
Genotype
1
1999
1835
0.010
 Why?
Sex Factors
1
1999
1965
0.010
 Why?
Macrophages
1
2000
1484
0.010
 Why?
Mice, Inbred C57BL
1
2003
5439
0.010
 Why?
Child, Preschool
1
1999
10459
0.000
 Why?
Child
1
1999
20785
0.000
 Why?
Pitts's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (396) concept(s)
_
Co-Authors Expand Description
See all (83) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)